Temasek-backed Chinese firm Innovent Biologics plans $422m HK IPO

Temasek-backed Chinese firm Innovent Biologics plans $422m HK IPO

Photo: REUTERS/JASON LEE

Chinese biotech firm Innovent Biologics is looking to raise up to $422 million in its Hong Kong IPO, three sources said, in what could be the biggest biotech IPO in the financial hub this year.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter